Enanta PharmaceuticalsENTA 
$6.287.17%24h
7.17%24h
Global rank18379
Market cap$131.69M
Change 7d4.67%
YTD Performance-32.62%
SP500 benchmarkUnderperform
P/E-0.98
P/S1.66
Revenue$79.20M
Earnings-$133.82M
Dividend yield-
Main Sector
Healthcare
Category
EPS for Enanta Pharmaceuticals (ENTA)
Enanta Pharmaceuticals has an EPS of $-6.38. In 2022, the company made an earnings per share (EPS) of $-5.91. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
EPS for ENTA
-
Value:-
EPS history for Enanta Pharmaceuticals from 2001 to 2023
| Year | EPS | Change |
|---|---|---|
| 2023 | -$6.38 | 7.95% |
| 2022 | -$5.91 | 50.77% |
| 2021 | -$3.92 | 116.57% |
| 2020 | -$1.81 | - |
View the highest EPS stocks
